Background: Aboriginal people in Canada are disproportionately affected by HIV and other blood-borne infections. A-Track is a national public health surveillance system designed to monitor HIV and related infections, behaviours and socio-demographic factors among Aboriginal populations in Canada. The pilot survey for the ATrack surveillance system, the first of its kind in Canada, was conducted in Regina, Saskatchewan and implemented via a community and public health partnership.
Introduction
In Canada, Aboriginal people remain disproportionately affected by HIV/AIDS. It is estimated that in 2011, Aboriginal people made up 12.2% of new HIV infections (1) . At the end of 2011, 8.9% of those living with HIV in Canada were Aboriginal people (1) . By comparison, Aboriginal people represented 4.3% of the Canadian population in the 2011 census (2) .
A-Track is a behavioural and biological surveillance system developed to monitor the prevalence of HIV and other related infections as well as associated risk behaviours and socio-demographics among Aboriginal populations in Canada. The A-Track system was piloted in Regina, Saskatchewan from 2011 to 2012. The focus of the pilot survey was to provide important surveillance information and determine whether this type of public health surveillance activity could be conducted in urban settings in Canada.
This report provides selected findings from the A-Track pilot survey and is a summary of a more in-depth report entitled Summary of key finding from the A-Track pilot survey, 2011 -2012 (3) .
Methods
A-Track is a behavioural and biological surveillance system that monitors the prevalence of HIV and other related infections as well as the associated risk behaviours and socio-demographics among Aboriginal populations in Canada. A pilot survey was launched in Regina, Saskatchewan, from December 5, 2011 to June 15, 2012.
The A-Track pilot survey was developed and implemented via a community and public health partnership. The partners included: a Community Advisory Group, All Nations Hope Network, Regina Qu'Appelle Health Region, the Canadian Aboriginal AIDS Network, First Nations University of Canada and the Public Health Agency of Canada.
The A-Track surveillance system recognizes Aboriginal peoples' shared control over data, respects Aboriginal customs and is based on the tenants of mutual respect between all stakeholders, the recognition of shared responsibility, Aboriginal community involvement and the utilization of existing local expertise. The surveillance system protocol recognizes First Nations, Inuit and Métis communities-specific culturally competent ethical research practices including the principles of data ownership, control, access and possession and protection (4) (6) . The data from the Regina pilot survey is managed collaboratively by the All Nations Hope Network, the Regina Qu'Appelle Health Region and the Public Health Agency of Canada.
The target population for the pilot survey was people who self-identified as Aboriginal (First Nations, Inuit or Métis) or claimed Aboriginal ancestry and were between the ages of 16 and 60 years. Participation was voluntary, completely anonymous and based on informed verbal consent. Participants were recruited from community-based organizations, Friendship Centres, healthcare service points and other relevant venues in Regina.
Consenting participants were asked to complete a questionnaire covering demographics, sexual behaviour, drug use, HIV and hepatitis C testing / treatment history, access to health services and HIV-related knowledge. Participants were also asked to provide a finger prick blood sample which was tested for HIV, hepatitis C and syphilis antibodies.
The data in this report are descriptive results shown for the overall sample (as well as by sex) allowing for comparisons between male and female participants for demographics, antibody laboratory results, sexual and drug use behaviours and HIV testing, care and treatment. Findings for self-reported HIV, sexually transmitted infection and tuberculosis infection status, access to health services and HIV-related knowledge are not presented here and can be obtained from the full report (3) . Where data in the table contain small cell counts, results should be interpreted with caution.
Results
A total of 1,064 individuals participated in the A-Track pilot survey, two of whom claimed Aboriginal ancestry and 1,062 of whom self-identified as Aboriginal. (Table 1 ) Of these 1,062, the majority (90.1%) self-identified as First Nations. Just over half (50.7%) of the participants were male and just under half (44.8%) of the participants were between the ages of 30 and 49 years, with a slightly lower proportion (42.2%) under the age of 29 years and over the age of 50 (13.0%). While the majority of participants (95.5%) self-reported their sexual orientation as heterosexual or straight, a significantly higher proportion of females than males self-identified as gay, lesbian, bisexual or other (6.9% versus 2.2%). Just over half (51.1%) of all participants who provided responses when asked about household income reported that their total household income was between $10,000 and $39,000. Significant differences were noted between the self-reported household incomes of males and females. Over half (60.2%) of the participants had less than a high school education, 19.5% had completed high school and 20.3% had some post-secondary education.
Just over half (53.2%) of all participants had been removed from their families during childhood; almost one-third (29.9%) had at some time during childhood lived in a residential or boarding school; and 43.4% had been placed in foster care at some time during childhood. No significant differences were noted between males and females.
While only 6.4% of all participants reported living exclusively in unstable housing during the 12 months prior to interview, 20.1% reported a mix of unstable and stable housing. A significantly higher proportion of male than female participants reported unstable housing as well as a mix of unstable and stable housing during the 12 months prior to interview. One-third of participants (33.3%) reported that they had moved for some reason within the 12 months prior to interview; no significant differences were noted between males and females.
Over half of all participants (57.7%) had, at some time in their lives, lived in a correctional facility; for male participants, this proportion was significantly higher as compared to female participants. The proportion of male participants who had lived in a correctional facility in the 12 months prior to interview was significantly higher than the proportion of female participants (7.2% versus 3.1%). HIV testing of dried blood spot (DBS) specimens was performed using the AVIOQ HIV-1 EIA assay. Confirmatory testing was subsequently performed using the Bio-Rad GS HIV-1 Western Blot assay. A positive result indicated a current HIV infection. 2 Participants who reported that their last HIV test result was positive and who were found to be HIV seropositive based on testing of the biological specimen provided at the time of interview were classified as being aware of their HIV positive status. 3 Hepatitis C testing of DBS specimens was performed using the Ortho HCV version 3.0 EIA. Confirmatory testing was not performed for samples that tested positive. A positive result indicated past or present hepatitis C infection and did not discriminate acute from chronic or resolved infections. 4 Syphilis testing was performed using the Serodia® Treponema pallidum particle agglutination assay (TP-PA). Confirmatory testing was not performed for samples that tested positive. A positive result was due either to false positivity or the presence of antibodies against syphilis, which indicated either past or present syphilis infection but did not distinguish acute from chronic or resolved infections. 5 Please note that due to small cell counts, Chi-squared results should be interpreted with caution.
Among the 1,045 participants who provided a blood sample of sufficient quantity for HIV testing, 54 participants (5.2%) were found to be HIV positive and no significant differences were found between males and females ( Table 2) . Of the 54 participants who tested positive for HIV, the majority of both males and females had a history of injection drug use; overall, 92.6% of all HIV seropositive participants reported that they had, at some time in their lives, used injection drugs. Just over half (55.8%) of the participants who were found to be HIV seropositive were aware of their HIV positive status and no significant differences were noted between males and females.
It is interesting to note that unawareness of HIV infection status was highest among participants who were HIV positive and who did not have a history of injection drug use. Among the 54 participants who tested positive for HIV, four had never injected and all of these participants (4/4; 100%) were unaware of their HIV positive status (data not shown). By contrast, among the 50 participants who tested positive for HIV and had a history of injection drug use, 42% (21/50) were unaware of their HIV positive status (data not shown).
Among the 1,044 participants who provided a sample of sufficient quantity for hepatitis C antibody testing, 41.6% were seropositive, with significantly higher proportions of males than females testing positive for hepatitis C exposure. A positive hepatitis C result indicates past or present hepatitis C infection and does not discriminate acute from chronic or resolved infections. Syphilis seroprevalence was very low among both males and females; overall, only 0.2% of participants were seropositive for syphilis. A positive syphilis result indicates past or present syphilis infection.
Although it is not possible to determine the proportion of participants that were co-infected with HIV and hepatitis C at the time of the survey due to the laboratory test used (i.e., it was not possible to distinguish present from past hepatitis C infection), 5.1% of participants were found to be seropositive for both HIV and hepatitis C. A significantly higher proportion of males than females tested positive for both HIV and hepatitis C antibodies. 1 Based on international reporting requirements through the Global AIDS Response Progress Report (GARPR), though the GARPR indicator is based on respondents who report injecting drugs in the last month rather than the last six months. 2 Participants were provided with a list of responses and were asked to check all those that applied to them. As participants could select more than one response, the total denominator is not shown.
Half of all participants (50.0%) reported that they had, at some time in their lives, used injection drugs, with a significantly higher proportion of male participants reporting a history of injection drug use (Table 3) . Among participants that reported having injected drugs at some time, 9.5% were found to be HIV seropositive based on testing of biological samples at the time of interview. Just under one-fifth (19.4%) of participants who had ever injected drugs reported that they had first done so before the age of 16; no significant differences were found between male and female participants. Overall, almost one-third of all participants (30.3%) had used injection drugs during the six months prior to interview, with no significant differences observed between males and females.
Of the 322 individuals who reported injection drug use in the six months prior to interview, the majority (98.8%) had used a clean needle and/or syringe during their last injection, with similar proportions observed among male and female participants. However, almost one-tenth (9.1%) had used a contaminated needle and/or syringe in the six months prior to interview and no significant differences were noted between males and females. With respect to the drugs or substances most commonly reported as being injected in the six months prior to interview, no significant differences were noted between males and females; cocaine, non-prescribed morphine and Ritalin were the three most commonly reported drugs used by both males and females. No significant differences were noted between males and females with respect to the people with whom they most often injected; among both males and females, friend(s) or people they knew well, followed by regular sex partner(s) were the most commonly reported persons with whom injection occurred. Among both males and females, their own apartment or house was the most commonly reported location of injection in the six months prior to interview.
Several of the sexual behaviour indicators listed in the table below are consistent with those required for international reporting, namely the Global AIDS Response Progress Report (GARPR). Refer to the footnotes for specification of which indicators are consistent with GARPR. It was found that a significantly higher proportion of male than female participants between the ages of 16 and 24 years had their first sexual intercourse prior to the age of 15 years (50.0% of males versus 34.0% of females) ( Table 4) . Just under half (42.7%) of all participants reported having had more than one sexual partner in the 12 months prior to interview, with similar proportions observed among males and females. Among those participants between the ages of 16 and 49 years who reported having more than one sexual partner in the 12 months prior to interview, a significantly higher proportion of male participants had used a condom at last sexual intercourse (57.7% of males versus 47.0% of females). Among those participants who reported having had a client sex partner in the 12 months prior to interview, 82.3% reported using a condom at last sexual intercourse and no significant differences were noted between males and females. Just under three-quarters (71.5%) of participants reported that they had been tested for HIV at least once during their lifetime, and history of HIV testing was significantly higher among female than male participants (Table 5) . Of the 750 individuals who had ever been tested for HIV, 67.6% had been tested during the 12 months prior to the interview, with similar proportions among males and females. Among participants who reported being HIV positive, 86.7% reported that they were under the care of a doctor at the time of the interview and 66.7% reported that they had, at some time, taken prescription drugs for HIV. No significant differences were found between males and females.
Conclusion
Findings from the A-Track pilot survey are consistent with other findings that suggest Aboriginal populations in Canada are disproportionately affected by HIV (7) (8) (9) (10) (11) (12) (13) (14) (15) . These findings also suggest that numerous risk behaviours may be contributing to the transmission of HIV and other blood-borne infections among Aboriginal populations and therefore underscore the continued need for health and social support services, as well as testing for HIV and other blood-borne infections. An analysis of the Aboriginal Social Determinants of Health would further inform service development and delivery by contextualizing the environments of risk and resilience that influence behaviours.
There are however limitations to the findings. The pilot survey only included Aboriginal people recruited at community and healthcare venues in Regina and thus, findings cannot be said to be representative of all Aboriginal people in Regina or of all Aboriginal people in Canada. In addition, the A-Track pilot survey findings are based on self-reported data and it is therefore possible that certain risk behaviours were over or underrepresented. These limitations notwithstanding, findings from the A-Track pilot survey -the first of its kind in Canada -provide valuable information for treatment and prevention services and programs at local, provincial and national levels. This surveillance data can be used to inform existing interventions and to design new strategies aimed at decreasing the risk of HIV and related infections among Aboriginal people in Canada.
In conclusion, this assessment of the pilot survey design and implementation processes and outputs has demonstrated the feasibility of such a behavioural and surveillance system for urban settings in Canada and provide lessons for use in future surveys of its kind.
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